AlphaYouAIM: Equels Thomas K discloses a purchase
By AlphaYouPublished Form 4
Equels Thomas K
Reporting filer
Equels Thomas K reported Purchase in AIM ImmunoTech Inc.: 11000 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 17, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Equels Thomas K | 2026-09-16 | P | Purchase | 11000 | 0.210 | 102,822 | 1 day | Filed terms
|
Common Stock
- Owner
- Equels Thomas K
- Date
- 2026-09-16
- Code
- P
- Action
- Purchase
- Quantity
- 11000
- Price
- 0.210
- Following holdings
- 102,822
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 11000
- transaction Price Per Share: 0.210
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 102822
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Equels Thomas K: CEO & President, Director.
Original sources
Prepared automatically from public filing data. Report a correction.